Osmol Therapeutics

Developer of treatments for chemotherapy-induced peripheral neuropathy (CIPN)

placeNew Haven, Connecticut, United States calendar_todayFounded 2016 groups2 employees language osmoltherapeutics.com

Registered entities

Social engagement

Social engagement: 531 social following, 9 posts in the last 12 months — above the industry median.

Investor mix

2 investors on record; lead investors include Koax Investment Partners.

Investor typeCountShare
Venture capital2100%

Recent activity

8 Dec 2025
Event
San Antonio Breast Cancer Symposium (SABCS)
24 Jul 2025
Milestone
regulatory
Coming soon